農業生技藥品檢測市場－2026-2031年預測

預計農業生技藥品檢測市場將從 2025 年的 20.85 億美元成長到 2031 年的 32.21 億美元，複合年成長率為 7.52%。

農業生技藥品涵蓋多種非合成材料，包括微生物接種劑（根瘤菌、菌根真菌、木黴屬、芽孢桿菌屬、植物促生根際細菌）、生物促效劑（海藻提取物、腐植酸/富裡酸、蛋白質水解物、亞磷酸鹽）、生物肥料和生物活性土壤改良劑（生物炭、對農物質萃取物），旨在提高對農養分、對農業產生潛力的減少和傳統產量。相關的檢測市場提供必要的第三方分析服務，用於產品註冊、功效檢驗、品管和功效驗證，並符合歐盟肥料產品法規 (FPR 2019/1009)、美國農業部國家有機計畫 (USDA NOP)、加拿大食品檢驗局 (CFIA) 和各國有機標準等框架。

需求主要受三個相互關聯的因素所驅動。首先，對合成農藥和無機肥料的監管日益嚴格（例如，歐盟「從農場到餐桌」戰略提出的到2031年實現25%有機農田的目標，以及各國對Glyphosate和新菸鹼類農藥的禁令），正在推動作物管理系統向生物基系統不可逆轉的轉變。其次，零售商和食品加工商對永續性的要求（例如，再生有機認證和範圍3脫碳承諾）日益要求生物材料的可驗證使用，迫使製造商投資於嚴格的認證檢驗，以區分真正有效的產品和普通替代品。第三，生物促效劑類別的快速擴張（目前是生物材料中成長最快的細分市場）需要先進的分析通訊協定，以便在田間條件下量化活性成分、微生物活力（CFU/g）和植物反應生物標記。

歐洲作為全球最大的有機市場，以及對新型肥料產品法規環境之一，憑藉其在農業生技藥品檢測的數量和價值方面持續領先全球。 2019/1009號肥料產品法規（FPR 2019/1009）的實施顯著提高了安全性、穩定性和功效數據的要求，實際上強制要求對微生物群落、污染物篩檢（重金屬、病原體）以及多季農藝性能測試進行符合良好實驗室規範（GLP）/經合組織（OECD）標準的第三方檢測。國家有機認證機構（ECOCERT、Bioland、土壤協會）和私人標準機構（Demeter、BioSuisse）透過要求進行額外的殘留物和微生物組影響評估，進一步提高了檢測的嚴格程度。

微生物接種劑和生物促效劑領域的檢測需求成長最為強勁。尋求歐盟CMC-7（微生物植物生物促效劑）或CMC-1（微生物）標籤的製造商必須提供全基因測序、16S/ITS分類鑑定、受控條件下的植物生長促進試驗以及土壤/根際殘留試驗。同樣，源自海藻萃取物和蛋白質水解物的生物促效劑需要對訊號分子（甜菜鹼、多胺、油菜素甾醇）進行精確定量分析，並進行氨基酸譜分析，以支持其關於耐旱性、根系發育和養分利用效率的標籤聲明。

北美正崛起為第二大土壤檢測中心，這主要得益於美國農業部有機農業計劃 (NOP) 認證需求的快速成長、各州層面的碳農業激勵措施（例如加州健康土壤計劃）以及大型作物保護公司向綜合生物平台轉型並迅速擴大生物材料的使用規模。食品公司再生農業舉措的推進以及對檢驗碳固存額度的需求，催生了對包含生物活性指標（酶活性測定、磷脂脂肪酸分析、透過 qPCR 檢測微生物負荷）的土壤健康檢測組合的新需求。

實驗室之間的競爭日益取決於認證範圍（ISO 17025、GLP、ISTA）、對時間敏感的微生物活力檢測結果的交付速度，以及提供多體學表徵（總體基因體學、代謝體學）以支持高級產品定位的能力。能夠從單一來源提供符合歐盟食品添加劑法規 (FPR) 的完整文件或符合美國農業部生物農藥和生物肥料註冊要求的實驗室，擁有顯著的定價權。

總之，農業生技藥品檢測市場已從一項小眾的合規職能發展成為支撐全球向永續農業轉型的重要基礎。隨著歐洲法規結構確立全球黃金標準，以及企業加速向生技藥品產品組合轉型，對先進、經認證的檢測服務的需求已鎖定多年結構性上升趨勢，且目前仍未出現飽和徵兆。

本報告的主要優勢：

• 深入分析：我們提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
• 競爭格局：了解全球主要企業的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
• 市場促進因素與未來趨勢：探索市場促進因素和關鍵趨勢及其對未來市場發展的影響。
• 可操作的建議：利用這些見解，在動態環境中做出策略決策，並開拓新的商機和收入來源。
• 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

本報告的使用範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

• 2021年至2025年的歷史數據和2026年至2031年的預測數據
• 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
• 競爭定位、策略和市場佔有率分析
• 按業務板塊和地區（包括國家）分類的收入和預測評估
• 公司概況（策略、產品、財務資訊）及主要發展動態

目錄

第1章執行摘要

第2章 市場概覽

• 市場概覽
• 市場定義
• 調查範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策與法規
• 策略建議

第4章 技術展望

5. 按產品分類的農業生技藥品檢測市場

• 介紹
• 生物農藥
• 生物肥料
• 生物促效劑
• 其他

6. 按應用分類的農業生技藥品檢測市場

• 介紹
• 現場支援
• 監管
• 分析
• 其他

7. 按地區分類的農業生技藥品檢測市場

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第8章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 合併、收購、協議和合作
• 競爭對手儀錶板

第9章：公司簡介

• Anadiag Group
• Apal Agricultural Laboratory
• Bionema Limited
• Biotecnologie BT Srl
• Eurofins Scientific SE
• i2LResearch
• Laus GmbH
• RJ Hill Laboratories Ltd
• SGS SA
• Staphyt SA

第10章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 調查方法
• 簡稱

Agriculture Biologicals Testing Market is forecasted to rise at a 7.52% CAGR, reaching USD 3.221 billion in 2031 from USD 2.085 billion in 2025.

Agriculture biologicals encompass a diverse portfolio of non-synthetic inputs-microbial inoculants (rhizobia, mycorrhizae, Trichoderma, Bacillus spp., PGPR), biostimulants (seaweed extracts, humic/fulvic acids, protein hydrolysates, phosphites), biofertilizers, and bioactive soil amendments (biochar, compost extracts)-designed to enhance nutrient uptake, stress resilience, and yield potential while reducing reliance on conventional agrochemicals. The associated testing market provides essential third-party analytical services for product registration, label claims verification, quality control, and efficacy demonstration under schemes such as EU Fertilising Products Regulation (FPR 2019/1009), USDA NOP, Canada CFIA, and various national organic standards.

Demand is structurally propelled by three interlocking forces. First, tightening regulatory restrictions on synthetic pesticides and mineral fertilizers-exemplified by the EU Farm-to-Fork 25 % organic land target by 2031 and national bans on glyphosate and neonicotinoids-are creating an irreversible push toward biologically based crop management systems. Second, retailer and food-processor sustainability mandates (e.g., Regenerative Organic Certified, Scope 3 decarbonization commitments) increasingly require verifiable use of biological inputs, driving manufacturers to invest in rigorous, accredited testing to differentiate genuine efficacy from commodity offerings. Third, the rapid expansion of the biostimulant category-now the fastest-growing segment within biologicals-necessitates sophisticated analytical protocols for quantifying active compounds, microbial viability (CFU/g), and plant-response biomarkers under field conditions.

Europe continues to dominate global agriculture biologicals testing volume and value, benefiting from the continent's position as both the largest organic market and the most stringent regulatory environment for novel fertilizing products. The implementation of FPR 2019/1009 has dramatically raised the bar for safety, stability, and efficacy data requirements, effectively mandating third-party GLP/OECD-compliant testing for microbial consortia, contaminant screening (heavy metals, pathogens), and multi-season agronomic performance trials. National organic certification bodies (ECOCERT, Bioland, Soil Association) and private standards (Demeter, BioSuisse) impose additional residue and microbiome-impact assessments that further deepen testing intensity.

The microbial inoculant and biostimulant segments are experiencing the strongest testing demand growth. Manufacturers pursuing EU CMC-7 (microbial plant biostimulant) or CMC-1 (micro-organism) claims must now provide whole-genome sequencing, taxonomic identification via 16S/ITS, plant-growth promotion assays under controlled conditions, and persistence studies in soil/rhizosphere. Similarly, seaweed-extract and protein-hydrolysate biostimulants require precise quantification of signaling molecules (betaines, polyamines, brassinosteroids) and amino-acid profiling to support label claims on drought tolerance, root development, or nutrient-use efficiency.

North America is emerging as the second major testing hub, driven by accelerating USDA NOP accreditation needs, state-level carbon farming incentives (California Healthy Soils Program), and the rapid scale-up of biologicals by major crop-protection players pivoting toward integrated biological platforms. The convergence of regenerative agriculture initiatives from food companies and the need for verifiable carbon-sequestration credits are creating new demand for soil health testing panels that include biological activity metrics (enzyme assays, PLFA, qPCR microbial abundance).

Competitive differentiation among testing laboratories increasingly hinges on accreditation scope (ISO 17025, GLP, ISTA), speed-to-result for time-sensitive microbial viability testing, and ability to offer multi-omic characterization (metagenomics, metabolomics) that supports premium product positioning. Laboratories capable of delivering fully compliant EU FPR dossiers or USDA biopesticide/biofertilizer registration packages under one roof command significant pricing power.

In conclusion, the agriculture biologicals testing market has evolved from a niche compliance function into a critical enabling infrastructure for the global transition to sustainable intensification. With Europe's regulatory framework setting the global gold standard and an accelerating corporate shift toward biological portfolios, demand for sophisticated, accredited testing services is locked into a multi-year structural uptrend that shows no sign of saturation.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Agriculture Biologicals Testing Market Segmentation:

BY PRODUCT

• Biopesticides
• Biofertilizers
• Biostimulants
• Others

BY APPLICATION

• Field Support
• Regulatory
• Analytical
• Others

BY GEOGRAPHY

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AGRICULTURE BIOLOGICALS TESTING MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Biopesticides
• 5.3. Biofertilizers
• 5.4. Biostimulants
• 5.5. Others

6. AGRICULTURE BIOLOGICALS TESTING MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Field Support
• 6.3. Regulatory
• 6.4. Analytical
• 6.5. Others

7. AGRICULTURE BIOLOGICALS TESTING MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. India
  • 7.6.3. Japan
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Anadiag Group
• 9.2. Apal Agricultural Laboratory
• 9.3. Bionema Limited
• 9.4. Biotecnologie B.T. Srl
• 9.5. Eurofins Scientific SE
• 9.6. i2LResearch
• 9.7. Laus GmbH
• 9.8. RJ Hill Laboratories Ltd
• 9.9. SGS SA
• 9.10. Staphyt S.A.

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key Benefits for the Stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations